| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 86, 1864-1871, Copyright © 1992 by American Heart Association
AA Quyyumi, RO Cannon 3d, JA Panza, JG Diodati and SE Epstein
BACKGROUND. A subgroup of patients with chest pain and angiographically
normal epicardial coronary arteries have reduced dilator response to
metabolic or pharmacological stimuli, but the mechanisms responsible for
this reduced dilator response are unknown. In this study, we have
investigated whether microvascular endothelial dysfunction is a cause of
the observed reduced vasodilator reserve. METHODS AND RESULTS. The
functional response of the microvasculature was studied with rapid atrial
pacing at 150 beats per minute. Fifty-one patients, 20 hypertensive and 31
normotensive, with chest pain and normal epicardial coronary arteries (<
10% stenosis) were studied. Endothelial function was tested with
incremental infusions of acetylcholine to achieve estimated intracoronary
concentrations ranging from 10(-7) M to 10(-5) M. Endothelium-independent
smooth muscle vasomotion was measured using intracoronary sodium
nitroprusside. Endothelial dysfunction of epicardial coronary arteries,
demonstrated as severe (> 50%) constriction with < 10(-5) M
acetylcholine concentration, was evident in five patients (10%). In the
remaining 46 patients, coronary blood flow increased with acetylcholine
(mean, 78 +/- 43%) and atrial pacing (mean, 51 +/- 37%), and coronary
vascular resistance decreased by 35 +/- 16% and 29 +/- 14%, respectively,
but the responses were heterogeneous. There was a correlation between the
coronary resistance change with acetylcholine and the change with atrial
pacing: r = 0.68, p < 0.001 in these 46 patients. Thus, patients with
depressed dilation with atrial pacing had reduced endothelium-dependent
dilation with acetylcholine, and vice versa. However, the microvascular
dilation caused by sodium nitroprusside was not significantly different
between patients with and those without reduced dilation with atrial
pacing, indicating that the vasodilator defect was not caused by smooth
muscle dysfunction. There were no differences in the vasodilator responses
with atrial pacing, acetylcholine, or nitroprusside between normotensive
and hypertensive patients. Multivariate regression analysis was performed
to determine whether age, sex, serum cholesterol level, hypertension,
presence of mild epicardial vessel atherosclerosis, resting left
ventricular function, change in left ventricular ejection fraction with
exercise, vasodilation with acetylcholine, and vasodilation with sodium
nitroprusside were independently related to the vasodilator response to
atrial pacing. Only the change in coronary vascular resistance with
acetylcholine was independently correlated with the change in resistance
with atrial pacing: R2 = 0.46, p < 0.0001. CONCLUSIONS. Patients with
chest pain, normal epicardial coronary arteries, and reduced vasodilation
in response to atrial pacing appear to have associated endothelial
dysfunction of the coronary microvasculature. Thus, microvascular
endothelial dysfunction may contribute to the reduced vasodilator reserve
with atrial pacing and anginal chest pain in these patients.
ARTICLES
Endothelial dysfunction in patients with chest pain and normal coronary arteries
Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
This article has been cited by other articles:
![]() |
N. Melikian, M. T. Kearney, M. R. Thomas, B. De Bruyne, A. M. Shah, and P. A. MacCarthy A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve Eur. Heart J., September 2, 2007; 28(18): 2188 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Johnson, L. J. Shaw, C. J. Pepine, S. E. Reis, S. F. Kelsey, G. Sopko, W. J. Rogers, S. Mankad, B. L. Sharaf, V. Bittner, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study Eur. Heart J., June 2, 2006; 27(12): 1408 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bugiardini and C. N. Bairey Merz Angina With "Normal" Coronary Arteries: A Changing Philosophy JAMA, January 26, 2005; 293(4): 477 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Rose, A. P. Carson, C. P. Sanford, P. E. Stang, C. A. Brown, A. R. Folsom, and M. Szklo Migraine and other headaches: Associations with Rose angina and coronary heart disease Neurology, December 28, 2004; 63(12): 2233 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bugiardini, O. Manfrini, C. Pizzi, F. Fontana, and G. Morgagni Endothelial Function Predicts Future Development of Coronary Artery Disease: A Study of Women With Chest Pain and Normal Coronary Angiograms Circulation, June 1, 2004; 109(21): 2518 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pizzi, O. Manfrini, F. Fontana, and R. Bugiardini Angiotensin-Converting Enzyme Inhibitors and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Cardiac Syndrome X: Role of Superoxide Dismutase Activity Circulation, January 6, 2004; 109(1): 53 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arroyo-Espliguero, N. Mollichelli, P. Avanzas, E. Zouridakis, V. R Newey, D. K Nassiri, and J. C. Kaski Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X Eur. Heart J., November 2, 2003; 24(22): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cosin-Sales, C. Pizzi, S. Brown, and J. C. Kaski C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1468 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Schindler, E Nitzsche, N Magosaki, I Brink, M Mix, M Olschewski, U Solzbach, and H Just Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation Heart, May 1, 2003; 89(5): 517 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Bonetti, L. O. Lerman, and A. Lerman Endothelial Dysfunction: A Marker of Atherosclerotic Risk Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 168 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.M.C. Rosano, M. Fini, and G. Mercuro Hormone replacement therapy in women with angina with normal coronary arteriograms. Pathogenetic or symptomatic therapy? Eur. Heart J., November 2, 2001; 22(22): 2051 - 2054. [PDF] |
||||
![]() |
P. K. Goel, S. K. Gupta, A. Agarwal, and A. Kapoor Slow Coronary Flow: A Distinct Angiographic Subgroup in Syndrome X Angiology, August 1, 2001; 52(8): 507 - 514. [Abstract] [PDF] |
||||
![]() |
A.D. Hughes and S. Thom Wearing your heart in your sleeve? Eur. Heart J., July 1, 2001; 22(13): 1071 - 1073. [PDF] |
||||
![]() |
A. Buffon, S. Rigattieri, S. A. Santini, V. Ramazzotti, F. Crea, B. Giardina, and A. Maseri Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2627 - H2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, S. Husain, W. Schenke, R. Mincemoyer, N. Epstein, and A. A. Quyyumi Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1467 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Buchthal, J. A. den Hollander, C. N. B. Merz, W. J. Rogers, C. J. Pepine, N. Reichek, B. L. Sharaf, S. Reis, S. F. Kelsey, and G. M. Pohost Abnormal Myocardial Phosphorus-31 Nuclear Magnetic Resonance Spectroscopy in Women with Chest Pain but Normal Coronary Angiograms N. Engl. J. Med., March 23, 2000; 342(12): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sztajzel, F. Mach, and A. Righetti Current concepts in medicine: Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries Postgrad. Med. J., January 1, 2000; 76(891): 16 - 21. [Abstract] [Full Text] |
||||
![]() |
I. D. Cox, H. E. Botker, J. P. Bagger, H. S. Sonne, B. O Kristensen, and J. C. Kaski Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms J. Am. Coll. Cardiol., August 1, 1999; 34(2): 455 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baller, G. Notohamiprodjo, U. Gleichmann, J. Holzinger, R. Weise, and J. Lehmann Improvement in Coronary Flow Reserve Determined by Positron Emission Tomography After 6 Months of Cholesterol-Lowering Therapy in Patients With Early Stages of Coronary Atherosclerosis Circulation, June 8, 1999; 99(22): 2871 - 2875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bottcher, H. E. Botker, H. Sonne, T. T. Nielsen, and J. Czernin Endothelium-Dependent and -Independent Perfusion Reserve and the Effect of L-arginine on Myocardial Perfusion in Patients With Syndrome X Circulation, April 13, 1999; 99(14): 1795 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, S. Husain, and A. A. Quyyumi Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin J. Am. Coll. Cardiol., March 1, 1999; 33(3): 796 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kal, I. Vergroesen, and H. B. van Wezel The Effect of Nitroglycerin on Pacing-Induced Changes in Myocardial Oxygen Consumption and Metabolic Coronary Vasodilation in Patients with Coronary Artery Disease Anesth. Analg., February 1, 1999; 88(2): 271 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Murakami, K. Urabe, and M. Nishimura Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1287 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F Bellamy, J. Goodfellow, A. C Tweddel, F. D.J Dunstan, M. J Lewis, and A. H Henderson Syndrome X and endothelial dysfunction Cardiovasc Res, November 1, 1998; 40(2): 410 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Quyyumi Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia?: A double-blind comparison of parenteral D- and L-Arginine J. Am. Coll. Cardiol., October 1, 1998; 32(4): 904 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frielingsdorf, P. Kaufmann, T. Suter, R. Hug, and O. M. Hess Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients Circulation, September 22, 1998; 98(12): 1192 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takata, A. Shimakura, S. Sakagami, Y. Nakamura, H. Ohkuwa, K.-i. Kobayashi, and H. Nagai Enhanced Insulin Response to Oral Glucose Load in Patients with Angina Pectoris Associated with ST Segment Elevation in the Absence of Epicardial Coronary Arterial Obstruction Angiology, September 1, 1998; 49(9): 815 - 826. [Abstract] [PDF] |
||||
![]() |
S. Makita, M. Nakamura, A. Ohira, S. Ito, K. Yoshioka, A. Hirose, T. Nakajima, K. Komoda, K. Kawazoe, and K. Hiramori Impaired Peripheral Vasodilation in Ischemic and Nonischemic Limbs of Patients with Unilateral Arteriosclerosis Obliterans: Effect of Revascularization on Leg Hemodynamics Vascular and Endovascular Surgery, September 1, 1998; 32(5): 491 - 502. [Abstract] [PDF] |
||||
![]() |
A. Lerman, J. C. Burnett Jr, S. T. Higano, L. J. McKinley, and D. R. Holmes Jr Long-term L-Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans Circulation, June 2, 1998; 97(21): 2123 - 2128. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Husain, N. P. Andrews, D. Mulcahy, J. A. Panza, and A. A. Quyyumi Aspirin Improves Endothelial Dysfunction in Atherosclerosis Circulation, March 3, 1998; 97(8): 716 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gauthier-Rein and N. J. Rusch Distinct Endothelial Impairment in Coronary Microvessels from Hypertensive Dahl Rats Hypertension, January 1, 1998; 31(1): 328 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, R. J. Gibbons, D. R. Holmes Jr, S. T. Higano, and A. Lerman Coronary Endothelial Dysfunction in Humans Is Associated With Myocardial Perfusion Defects Circulation, November 18, 1997; 96(10): 3390 - 3395. [Abstract] [Full Text] |
||||
![]() |
K. Egashira, Y. Hirooka, T. Kuga, M. Mohri, and A. Takeshita Effects of L-Arginine Supplementation on Endothelium-Dependent Coronary Vasodilation in Patients With Angina Pectoris and Normal Coronary Arteriograms Circulation, July 15, 1996; 94(2): 130 - 134. [Abstract] [Full Text] |
||||
![]() |
T. Kadokami, K. Egashira, K. Kuwata, Y. Fukumoto, T. Kozai, H. Yasutake, T. Kuga, H. Shimokawa, K. Sueishi, and A. Takeshita Altered Serotonin Receptor Subtypes Mediate Coronary Microvascular Hyperreactivityin Pigs With Chronic Inhibitionof Nitric Oxide Synthesis Circulation, July 15, 1996; 94(2): 182 - 189. [Abstract] [Full Text] |
||||
![]() |
J. Frielingsdorf, C. Seiler, P. Kaufmann, G. Vassalli, T. Suter, and O. M. Hess Normalization of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypertension Circulation, April 1, 1996; 93(7): 1380 - 1387. [Abstract] [Full Text] |
||||
![]() |
A. A. Quyyumi, N. Dakak, N. P. Andrews, D. M. Gilligan, J. A. Panza, and R. O. Cannon III Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart Circulation, August 1, 1995; 92(3): 320 - 326. [Abstract] [Full Text] |
||||
![]() |
A. M. Zeiher, T. Krause, V. Schachinger, J. Minners, and E. Moser Impaired Endothelium-Dependent Vasodilation of Coronary Resistance Vessels Is Associated With Exercise-Induced Myocardial Ischemia Circulation, May 1, 1995; 91(9): 2345 - 2352. [Abstract] [Full Text] |
||||
![]() |
C. J. H. Jones, L. Kuo, M. J. Davis, D. V. DeFily, and W. M. Chilian Role of Nitric Oxide in the Coronary Microvascular Responses to Adenosine and Increased Metabolic Demand Circulation, March 15, 1995; 91(6): 1807 - 1813. [Abstract] [Full Text] |
||||
![]() |
P. J. Nahser Jr, R. E. Brown, H. Oskarsson, M. D. Winniford, and J. D. Rossen Maximal Coronary Flow Reserve and Metabolic Coronary Vasodilation in Patients With Diabetes Mellitus Circulation, February 1, 1995; 91(3): 635 - 640. [Abstract] [Full Text] |
||||
![]() |
R. O. Cannon Chest Pain with Normal Coronary Angiograms N. Engl. J. Med., June 10, 1993; 328(23): 1706 - 1708. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |